EX-23.1 4 d135914dex231.htm EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We have issued our reports dated March 15, 2016, with respect to the consolidated financial statements and internal control over financial reporting, included in the Annual Report of StemCells, Inc. and subsidiaries on Form 10-K for the year ended December 31, 2015. We consent to the incorporation by reference of said reports in the Registration Statements of StemCells, Inc. and subsidiaries on Form S-1 (File No. 333-61726, effective May 25, 2001 and amended on June 29, 2001 and July 2, 2011), on Forms S-3 (File Nos. 333-193100, effective December 27, 2013; 333-170300, effective November 16, 2010; 333-159604, effective May 29, 2009; 333-151891, effective June 24, 2008 and amended on July 18, 2008; 333-117360, effective July 14, 2004; 333-105664, effective May 29, 2003 and amended on June 3, 2003; 333-83992, effective March 8, 2002 and amended on July 2, 2002; 333-75806, effective December 21, 2001 and amended on January 1, 2009; and 333-66692, effective August 3, 2001 and amended on August 8, 2001), on Forms S-8 (File Nos. 333-66700, effective August 3, 2001; 333-118263, effective August 16, 2004; 333-144747, effective July 20, 2007; 333-183712, effective September 4, 2012; and 333-190386, effective August 6, 2013), and in the Registration Statements of CytoTherapeutics, Inc. on Forms S-3 (File Nos. 33-91228, effective April 14, 1995; and 33-68900, effective September 15, 1993).

/s/ GRANT THORNTON LLP

San Francisco, California

March 15, 2016